..
Molnupiravir, an oral pill used for treating mild to moderate cases of #COVID19, is now available through the telemedicine program of the OVP and in Manila City.
— ABS-CBN News Channel (@ANCALERTS) November 23, 2021
READ: https://t.co/Bl1iy07Np1 pic.twitter.com/ox1eUM1S1R
..
US-based Merck & Co Inc and Ridgeback Biotherapeutics are recruiting patients in the Philippines for the Phase 3 Clinical Trial of Molnupiravir, an oral antiviral treatment for #COVID19. https://t.co/IjoMSZQCAn
— ABS-CBN News (@ABSCBNNews) November 23, 2021
..
..
RiteMed and Faberco have agreed to a strategic partnership to help provide quality and affordable treatment solutions not only to Covid-19 but also to other diseases that impact on public health. Molnupiravir, developed by Merck & Co. (MSD).
— BusinessMirror (@BusinessMirror) November 17, 2021
..
weehingthong 